DEXCOM INC·4

Mar 27, 5:08 PM ET

Pacelli Steven Robert 4

4 · DEXCOM INC · Filed Mar 27, 2023

Insider Transaction Report

Form 4
Period: 2023-03-23
Transactions
  • Sale

    Common Stock

    2023-03-23$116.40/sh5,442$633,449138,129 total
Footnotes (2)
  • [F1]On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  • [F2]Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT